1Atsushi S,Tamai I,Kawazu K,et al.In vivo evidence for ATP-dependent and P-glycoprotein mediated tra_nsport of cyclosporin A at the blood brain barrier[].Biochemical Pharmacology.1994 被引量:1
2Lown KS,Mayo RR,Leichtman AB,et al.Role of in_testinal P-glycoprotein(mdr 1) in interpatient variation in the oral bioavailabilit y of cyclosporine[].Clinical Pharmacology and Therapeutics.1997 被引量:1
3Schinkel AH,Wagenaar E,Deemter LV,et al.Absen_ce of the mdr 1a P-proglyprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone,di goxin and cyclosporin A[].The Journal of Clinical Investigation.1995 被引量:1
4Sparreboom A,Van Asperen J,Mayer U,et al.Limited oral bioavailabilit y and active epithelial excretion of pa_clitaxel caused by P-glycoprotein in the intestine[].Proceedings of the National Academy of Sciences of the United States of America.1997 被引量:1
5Fricker G,Drewe J,Huwyler J,et al.Relevance of P-glycoprotein for the enteral absprption of cyclospor_in A: in vitro-in vivo correlation[].British Journal of Pharmacology.1996 被引量:1
6Amsden GW,Nafzi ger AN,Foulds G,et al.A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers[].Journal of Clinical Pharmacology.2000 被引量:1
7Meerum TJM,Malingre MM,Bei j nen JH,et al.Coa_dministration of oral cyclosporin A enables oral therapy with paclitaxel[].Clinical Cancer Research.1999 被引量:1
8Van Asperen J,Schinkel AH,Bei j nen JM,et al.Altered pharmacokinetics of vinblastine in Mdr 1a P-gly_coprotein deficient mice[].Journal of the National Cancer Institute.1996 被引量:1
9Britten CD,Baker SD,Denis LJ,et al.Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel[].Clinical Cancer Research.2000 被引量:1
10Tamai I,Safa AR.Competitive interaction of cyclospor_ins with the vinca alkaloid-binding site of P-glycopro_tein in multidrug resistant cells[].Journal of Biological Chemistry.1990 被引量:1